SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-19-012706
Filing Date
2019-11-12
Accepted
2019-11-12 16:05:30
Documents
42
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT mnpr_form10q09302019.htm 10-Q 667042
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit311.htm EX-31.1 11752
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF exhibit312.htm EX-31 11067
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE exhibit321.htm EX-32 8570
  Complete submission text file 0001654954-19-012706.txt   2053607

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT mono-20190930.xml EX-101.INS 279833
6 XBRL TAXONOMY EXTENSION SCHEMA mono-20190930.xsd EX-101.SCH 18141
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mono-20190930_cal.xml EX-101.CAL 26309
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mono-20190930_def.xml EX-101.DEF 42777
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mono-20190930_lab.xml EX-101.LAB 138583
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mono-20190930_pre.xml EX-101.PRE 110546
Mailing Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091
Business Address 1000 SKOKIE BLVD SUITE 350 WILMETTE IL 60091 8473880349
Monopar Therapeutics (Filer) CIK: 0001645469 (see all company filings)

IRS No.: 320463781 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39070 | Film No.: 191209282
SIC: 2834 Pharmaceutical Preparations